Skip to main content

Keratosis News

Adding 3D Total Body Photography to Usual Care Increases Rate of Skin Excisions

WEDNESDAY, March 26, 2025 – The addition of three-dimensional (3D) total-body photography (TBP) and sequential digital dermoscopy imaging (SDDI) via teledermatology to usual care increases the...

Aclaris Therapeutics Receives FDA Approval for Eskata (hydrogen peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses

MALVERN, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) – Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that the U.S. Food and Drug Administration...

FDA Medwatch Alert: Picato (ingenol mebutate) Gel: Drug Safety Communication - FDA Warns of Severe Adverse Events, Requires Label Changes

ISSUE: FDA is warning about reports of severe allergic reactions and herpes zoster (shingles) associated with the use of Picato gel (ingenol mebutate). FDA received reports of cases involving severe...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Actinic Keratosis

Related drug support groups

Efudex